Press Release Bluestar Genomics Presents New Data Showing Its Liquid Biopsy Test Detects Pancreatic Cancer Signal ClearNote Health November 5, 2021
Press Release Bluestar Genomics Closes $70M Series C Funding, Expands Scientific Advisory Board ClearNote Health May 12, 2021
Press Release Bluestar Genomics Receives FDA Breakthrough Device Designation for First-of-Its-Kind Pancreatic Cancer Screening Test ClearNote Health March 31, 2021
